A citation-based method for searching scientific literature

Valentin Benboubker, Félix Boivin, Stéphane Dalle, Julie Caramel. Front Immunol 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response.
Patricio Godoy, Cristina Cadenas, Birte Hellwig, Rosemarie Marchan, Joanna Stewart, Raymond Reif, Miriam Lohr, Matthias Gehrmann, Jörg Rahnenführer, Markus Schmidt,[...]. Breast Cancer 2014
70
100

Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity.
Chien-Chun Steven Pai, Donald M Simons, Xiaoqing Lu, Michael Evans, Junnian Wei, Yung-Hua Wang, Mingyi Chen, John Huang, Chanhyuk Park, Anthony Chang,[...]. J Clin Invest 2019
67
100

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors.
Hojabr Kakavand, Robert V Rawson, Gulietta M Pupo, Jean Y H Yang, Alexander M Menzies, Matteo S Carlino, Richard F Kefford, Julie R Howle, Robyn P M Saw, John F Thompson,[...]. Clin Cancer Res 2017
46
100

Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients.
Brigitte Dréno, Amir Khammari, Agnès Fortun, Virginie Vignard, Soraya Saiagh, Tiffany Beauvais, Nicolas Jouand, Sylvain Bercegay, Sylvain Simon, François Lang,[...]. Cancer Immunol Immunother 2021
4
100

Induction of Progenitor Exhausted Tissue-Resident Memory CD8+ T Cells Upon Salmonella Typhi Porins Adjuvant Immunization Correlates With Melanoma Control and Anti-PD-1 Immunotherapy Cooperation.
Ricardo A León-Letelier, Daniel I Castro-Medina, Oscar Badillo-Godinez, Araceli Tepale-Segura, Enrique Huanosta-Murillo, Cristina Aguilar-Flores, Saraí G De León-Rodríguez, Alejandra Mantilla, Ezequiel M Fuentes-Pananá, Constantino López-Macías,[...]. Front Immunol 2020
4
100

Zebrafish modeling reveals that SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment.
Elena Gómez-Abenza, Sofía Ibáñez-Molero, Diana García-Moreno, Inmaculada Fuentes, Leonard I Zon, Maria C Mione, María L Cayuela, Chiara Gabellini, Victoriano Mulero. J Exp Clin Cancer Res 2019
21
100

UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color: A Systematic Review.
Fabiana C P S Lopes, Marc G Sleiman, Kate Sebastian, Roxanne Bogucka, Elizabeth A Jacobs, Adewole S Adamson. JAMA Dermatol 2021
24
100


Rsad2 is necessary for mouse dendritic cell maturation via the IRF7-mediated signaling pathway.
Ji-Su Jang, Jun-Ho Lee, Nam-Chul Jung, So-Yeon Choi, Soo-Yeoun Park, Ji-Young Yoo, Jie-Young Song, Han Geuk Seo, Hyun Soo Lee, Dae-Seog Lim. Cell Death Dis 2018
29
100

Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy.
Laura A Huppert, Michael D Green, Luke Kim, Christine Chow, Yan Leyfman, Adil I Daud, James C Lee. Cell Mol Immunol 2022
13
100

A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients.
Chuan Li, Yee Peng Phoon, Keaton Karlinsey, Ye F Tian, Samjhana Thapaliya, Angkana Thongkum, Lili Qu, Alyssa Joyce Matz, Mark Cameron, Cheryl Cameron,[...]. J Exp Med 2022
6
100

Epigenetic regulation of OAS2 shows disease-specific DNA methylation profiles at individual CpG sites.
Xiaolian Gu, Linda Boldrup, Philip J Coates, Robin Fahraeus, Elisabet Nylander, Christos Loizou, Katarina Olofsson, Lena Norberg-Spaak, Ola Gärskog, Karin Nylander. Sci Rep 2016
19
100

Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030.
Gery P Guy, Cheryll C Thomas, Trevor Thompson, Meg Watson, Greta M Massetti, Lisa C Richardson. MMWR Morb Mortal Wkly Rep 2015
279
100

Progress and challenges of immunotherapy in triple-negative breast cancer.
Yinxing Zhu, Xuedan Zhu, Cuiju Tang, Xiaoxiang Guan, Wenwen Zhang. Biochim Biophys Acta Rev Cancer 2021
31
100


Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
Christine E Boone, Lu Wang, Aayushma Gautam, Isabel G Newton, Nicole F Steinmetz. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022
8
100



Reinvigorating exhausted CD8+ cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy.
Md Amir Hossain, Guilai Liu, Beiying Dai, Yaxuan Si, Qitao Yang, Junaid Wazir, Lutz Birnbaumer, Yong Yang. Med Res Rev 2021
19
100

Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective.
Sijia Gu, Ling Qian, Yalei Zhang, Kun Chen, Ye Li, Jia Wang, Peng Wang. Biochim Biophys Acta Rev Cancer 2021
2
100

Intratumour microbiome associated with the infiltration of cytotoxic CD8+ T cells and patient survival in cutaneous melanoma.
Gongjian Zhu, Haixiang Su, Caroline H Johnson, Sajid A Khan, Harriet Kluger, Lingeng Lu. Eur J Cancer 2021
17
100

GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway.
Shuye Yu, Xiaoting Yu, Lili Sun, Yanwen Zheng, Lili Chen, Hui Xu, Jing Jin, Qing Lan, Clark C Chen, Ming Li. Oncogene 2020
27
100

SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.
Siwen Hu-Lieskovan, Srabani Bhaumik, Kavita Dhodapkar, Jean-Charles J B Grivel, Sumati Gupta, Brent A Hanks, Sylvia Janetzki, Thomas O Kleen, Yoshinobu Koguchi, Amanda W Lund,[...]. J Immunother Cancer 2020
9
100


Immunotherapy in colorectal cancer.
Parul Agarwal, Dung T Le, Patrick M Boland. Adv Cancer Res 2021
8
100

Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy.
Iris Lodewijk, Sandra P Nunes, Rui Henrique, Carmen Jerónimo, Marta Dueñas, Jesús M Paramio. Clin Epigenetics 2021
11
100

ZEB1 transcription factor promotes immune escape in melanoma.
Maud Plaschka, Valentin Benboubker, Maxime Grimont, Justine Berthet, Laurie Tonon, Jonathan Lopez, Myrtille Le-Bouar, Brigitte Balme, Garance Tondeur, Arnaud de la Fouchardière,[...]. J Immunother Cancer 2022
6
100

The Influence of Tumor Microenvironment on Immune Escape of Melanoma.
Aleksandra Simiczyjew, Ewelina Dratkiewicz, Justyna Mazurkiewicz, Marcin Ziętek, Rafał Matkowski, Dorota Nowak. Int J Mol Sci 2020
37
100

Deciphering the Roles of IFITM1 in Tumors.
Renba Liang, Xinxiao Li, Xiaodong Zhu. Mol Diagn Ther 2020
15
100

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.
Gabriela Bindea, Bernhard Mlecnik, Marie Tosolini, Amos Kirilovsky, Maximilian Waldner, Anna C Obenauf, Helen Angell, Tessa Fredriksen, Lucie Lafontaine, Anne Berger,[...]. Immunity 2013
100

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Piotr Rutkowski, Jean-Jacques Grob, C Lance Cowey, Christopher D Lao, John Wagstaff, Dirk Schadendorf, Pier F Ferrucci,[...]. N Engl J Med 2017
100

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
Alberto Mantovani, Silvano Sozzani, Massimo Locati, Paola Allavena, Antonio Sica. Trends Immunol 2002
100

Aetiology and Pathogenesis of Cutaneous Melanoma: Current Concepts and Advances.
Strahil Strashilov, Angel Yordanov. Int J Mol Sci 2021
9
100

Mx GTPases: dynamin-like antiviral machines of innate immunity.
Otto Haller, Peter Staeheli, Martin Schwemmle, Georg Kochs. Trends Microbiol 2015
265
100

IRF-2 inhibits cancer proliferation by promoting AMER-1 transcription in human gastric cancer.
Yan-Jie Chen, Shu-Neng Luo, Hao Wu, Ning-Ping Zhang, Ling Dong, Tao-Tao Liu, Li Liang, Xi-Zhong Shen. J Transl Med 2022
3
100

The immune contexture in cancer prognosis and treatment.
Wolf H Fridman, Laurence Zitvogel, Catherine Sautès-Fridman, Guido Kroemer. Nat Rev Clin Oncol 2017
100

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma.
M Oliva, A Spreafico, M Taberna, L Alemany, B Coburn, R Mesia, L L Siu. Ann Oncol 2019
104
100


Molecular cloning, GTP recognition mechanism and tissue-specific expression profiling of myxovirus resistance (Mx) protein in Labeo rohita (Hamilton) after Poly I:C induction.
Basanta Kumar Das, Pragyan Roy, Ajaya Kumar Rout, Deepak Ranjan Sahoo, Soumya Prasad Panda, Sushmita Pattanaik, Budheswar Dehury, Bijay Kumar Behera, Sudhansu Sekhar Mishra. Sci Rep 2019
10
100


Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside.
Darleny Y Lizardo, Chaoyuan Kuang, Suisui Hao, Jian Yu, Yi Huang, Lin Zhang. Biochim Biophys Acta Rev Cancer 2020
44
100


Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response.
Piper A Rawding, Jiyoon Bu, Jianxin Wang, Da Won Kim, Adam J Drelich, Youngsoo Kim, Seungpyo Hong. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022
4
100



MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer.
Chen Liang, Xing Zhang, Hui-Min Wang, Xiao-Min Liu, Xin-Ju Zhang, Bo Zheng, Guang-Ren Qian, Zhong-Liang Ma. Cell Death Dis 2017
87
100

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
James Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer,[...]. N Engl J Med 2019
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.